We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives.
Our teams across the world strive to transform the practice of medicine, turning the impossible into the possible for patients.
We provide potentially life-changing treatments and the protection of life-saving vaccines to millions of people, and affordable access to our medicines in some of the world’s poorest countries. www.sanofi.com
CSL Behring’s portfolio of innovative medicines includes a wide range of recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and Alpha-1 Antitrypsin Deficiency.
Check here for more information about www.cslbehring.com
Boehringer Ingelheim has over 100 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area, having launched several treatments in a range of respiratory conditions including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and lung cancer. Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life.
Check here for more information about www.boehringer-ingelheim.com